Skip to main content

Table 1 Comparison between the interviewed immigrants in the study and all immigrants with tuberculosis diagnosed in 2005

From: Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands

 

Immigrant TB patients in 2005, N (%)*

Study population, N (%)*

P-value Chi-square

Total

762 (100)

60 (100)

 

Sex

  

0.49

Male

448 (59)

38 (63)

 

Female

314 (41)

22 (37)

 

Age (yr)

  

0.08

18–24

150 (20)

18 (30)

 

25–44

386 (51)

33 (55)

 

45–64

154 (20)

8 (13)

 

≥ 65

71 (9)

1 (2)

 

Unknown

1 (0)

0 (0)

 

Generation

  

0.43

First generation immigrant

718 (94)

58 (97)

 

Second generation immigrant

44 (6)

2 (3)

 

Region of origin

  

0.44

Europe

92 (12)

3 (5)

 

America (Central and South)

72 (9)

6 (10)

 

America (North)

1 (0)

0 (0)

 

Asia

249 (33)

18 (30)

 

Africa

338 (44)

33 (55)

 

Unknown

10 (1)

0 (0)

 

Localisation of TB

  

0.69

Pulmonary

357 (47)

31 (52)

 

Extrapulmonary

305 (40)

23 (38)

 

Pulmonary and extrapulmonary

100 (13)

6 (10)

 

Culture result

  

0.83

Positive

531 (70)

44 (73)

 

Negative

91 (12)

6 (10)

 

Not done/unknown

140 (18)

10 (17)

 

Previously diagnosed with TB

  

0.13

No

611 (80)

54 (90)

 

Yes

46 (6)

3 (5)

 

Unknown

105 (14)

3 (5)

 

Treatment regime

  

< 0.01

Standard (4HRZ(E)/2HR(E))

542 (71)

43 (72)

 

Other

220 (29)

9 (15)

 

Unknown

0 (0)

8 (13)

 

Impaired immunity

  

< 0.01

No

282 (37)

40 (67)

 

Yes

140 (18)

4 (7)

 

Missing

340 (45)

16 (27)

 

Hospitalization (during TB treatment for at least 7 days)

  

0.16

No

438 (58)

29 (48)

 

Yes

232 (30)

19 (32) ‡

 

Unknown

92 (12)

12 (20)

 
  1. Definition of abbreviations: H = isoniazid; R = rifampin; Z = pyrazinamid; E = ethambutol;
  2. * Column percentages are given
  3. ‡ This number differs from that in Table 2 because a different definition for hospitalization is used in the NTR-database.